575765767958290

Raytheon Company

June 26, 2015Judge Delman
Partially SustainedCost Allowability / Allocability (FAR 31)Cost Accounting Standards (CAS)Indirect Rates / Incurred CostQuantum / DamagesCDA JurisdictionStatutory ComplianceAccord & Satisfaction / Release / WaiverDCAA InvolvedDCMA InvolvedCAS at Issue

Raytheon Company challenged government monetary claims alleging CAS 405 and FAR violations arising from the treatment of bonus and incentive compensation and long-term performance plan stock awards. On cross-motions for summary judgment, the Board granted relief to each side on different issues, dismissed part of one appeal for lack of jurisdiction, and left damages and certain factual issues unresolved.

Material Facts

  • Raytheon's corporate home office used performance sharing, results-based incentives, restricted stock, and long-term performance plan compensation programs.
  • Raytheon's LTPP was deferred compensation and a component of its 2001 Stock Plan.
  • Under the LTPP, participants could earn shares based on specified company-performance metrics over a three-year performance cycle.
  • For the relevant LTPP cycles, Raytheon calculated the TSR metric using ending stock price, three years of dividends, and beginning stock price, and compared the result with ten peer companies.
  • A higher relative TSR ranking generally resulted in additional shares, while a lower ranking resulted in fewer shares.
  • Raytheon withdrew labor and a portion of fringe expenses for employees engaged in expressly unallowable advertising, lobbying, organization, and legal activities, but did not withdraw the applicable portion of bonus, restricted stock, and other incentive compensation.
  • The government's final decision under ASBCA No. 57576 identified activities under FAR 31.205-1, FAR 31.205-22, FAR 31.205-27, and FAR 31.205-47, but did not assert a claim under FAR 31.205-8 for contributions activities.
  • DCAA audits included reviews of Raytheon's bonus payments, forward pricing submissions, long-term incentive plans, overhead cost submission, and incurred cost submissions.
  • The DCAA work paper stated an auditor's view that LTPP costs were allowable because the shares were based on stock price compared with peers rather than strictly on a change in Raytheon stock price.
  • The CACO later issued final decisions asserting that TSR-related costs were expressly unallowable under FAR 31.205-6(i).

Parties

Appellant
Raytheon Company
Respondent Agency
Defense Contract Management Agency
Contract Number
FA8807-06-C-0004; NOOO 19-06-C-03 l 0
Open Official Decision PDF (asbca.mil)AI-analyzed, grounded in the decision text. Verify against the official PDF before relying on it.

Full Legal Analysis

Create a free account to read the complete grounded legal brief for this decision, including the holding, every issue the Board decided, quantum, verified citations, and the case's citation graph.

Holding & Legal Reasoning

The Board's holding, background, and procedural posture for this decision.

Issues Presented

Every issue the Board decided, with its determination, reasoning, and supporting authority.

Quantum & Recovery

The claimed, awarded, and net dollar amounts at issue, itemized where the record supports it.

Verified Authorities & Citations

Every cited FAR, DFARS, CAS, and case-law authority, cross-checked against the source text.

Practitioner Takeaways

Practical guidance for contractors and counsel, distilled from the Board's ruling.

Similar Cases

Related decisions surfaced by semantic search across the full analyzed corpus.

Citation Graph

An interactive graph of this case's cited authorities, judge, agency, and related decisions.

Related Decisions

Same Judge

Same Year

Same Issue

Newsletter

New decisions every Monday

GovConDash Weekly lists the decisions GAO, the boards, the courts and SBA OHA released that week, alongside the FAR Overhaul deviations and proposed rules that reach every contractor. Free.

Free, weekly, and one click to unsubscribe. We send a confirmation email first. See our Privacy Policy.